MYC and TFEB Control DNA Methylation and Differentiation in AML.
暂无分享,去创建一个
[1] A. Ballabio,et al. TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia. , 2020, Blood cancer discovery.
[2] M. Roussel,et al. MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat , 2019, Nature Communications.
[3] R. Eisenman,et al. The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis , 2018, Frontiers of Medicine.
[4] A. Ballabio,et al. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization , 2018, The EMBO journal.
[5] K. Helin,et al. Role of TET enzymes in DNA methylation, development, and cancer , 2016, Genes & development.
[6] C. Dang,et al. MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells. , 2015, Cell Metabolism.
[7] D. Ferguson,et al. Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia , 2015, Cell Death Discovery.
[8] M. Konopleva,et al. Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML , 2015, American journal of hematology.
[9] O. Sansom,et al. The role of MIZ-1 in MYC-dependent tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.